NCT01091740View on ClinicalTrials.gov

ComparisiOn of Neointimal coVerage betwEen ZES and EES Using OCT at 3 Months

PHASE4CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

August 31, 2009

Primary Completion Date

August 31, 2010

Study Completion Date

August 31, 2010

Conditions
Coronary Artery Disease
Interventions
DEVICE

ZES resolute (Endeavor Resolute)

2nd generation drug eluting stent, which is coated with zotarolimus

DEVICE

EES (Xience)

2nd generation drug eluting stent, which is coated with everolimus

Trial Locations (2)

700-712

Dongsan Medical Center, Keimyung University College of Medicine, Daegu

120-752

Division of Cardiology, Cardiovascular Hospital, Yonsei University, Seoul

Sponsors

Collaborators (1)

Medtronic
All Listed Sponsors
collaborator

Medtronic

INDUSTRY

lead

Yonsei University

OTHER